MP08: Bladder Cancer: Non-invasive I

Poster Session Moderator(s)

• BG

  Boris Gershman, MD

  Rhode Island Hospital and The Miriam Hospital
• 

  Mary Westerman, MD (she/her/hers)

  Associate Professor of Urology
  LSU Health Science Center, New Orleans - Department of Urology

Presentations:

• 9:30 AM – 11:30 AM CST

  MP08-01: Immunosuppressive mechanisms of integrin beta8 for immune response induced by BCG therapy
  

  Poster Presenter: Seiji Hoshi
• 9:30 AM – 11:30 AM CST

  MP08-02: Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with high-risk non-muscle-invasive bladder cancer
  

  Poster Presenter: Naoki Fujita, MD
• 9:30 AM – 11:30 AM CST

  MP08-03: Progression-free survival as surrogate endpoint in high-risk non-muscle invasive bladder cancer studies: results from a machine learning-based analysis of a large multi-institutional database
  

  Poster Presenter: Michele Marchioni, PhD (he/him/his)
• 9:30 AM – 11:30 AM CST

  MP08-04: Use of Antibiotics in Patients Undergoing Follow-up for Non-muscle invasive bladder cancer with either Flexible cystoscopy or the Urinary Biomarker Test Xpert® Bladder Cancer Monitor: a secondary Outcome from a Randomised Clinical Trial
  

  Poster Presenter: Thomas Karmark Dreyer, MD,Phd
• 9:30 AM – 11:30 AM CST

  MP08-05: Phase 1a/b Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer
  

  Poster Presenter: William Borj Tabayoyong, MD – Department of Urology
• 9:30 AM – 11:30 AM CST

  MP08-06: Outcomes for High-Risk Bladder Cancer after BCG Therapy in Patients with prior Prostate Radiotherapy: A SEER-Based Study
  

  Poster Presenter: Adri Durant, MD
• 9:30 AM – 11:30 AM CST

  MP08-07: Is pelvic lymph node dissection necessary in NMIBC patients undergoing RC?
  

  Poster Presenter: Qiang Lyu, MD
• 9:30 AM – 11:30 AM CST

  MP08-08: En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-matched Analysis
  

  Poster Presenter: Takafumi Yanagisawa, MD – The Jikei University School of Medicine
• 9:30 AM – 11:30 AM CST

  MP08-09: Down-staging in AUA risk stratification after intravesical bacillus Calmette-Guerin therapy has favorable effect on recurrence free survival after 2nd line intravesical gemcitabine chemotherapy
  

  Poster Presenter: Byeong Jin Jin Kang, MD (he/him/his) – Pusan National University Hospital
• 9:30 AM – 11:30 AM CST

  MP08-10: Global Variation in Early Recurrence After Transurethral Resection of Bladder Tumor in the RESECT study (NCT05154084): There is Significant Inter-site Variation that is Independent of Differences in Tumour Factors
  

  Poster Presenter: Betty Houjiazi Wang, MD (she/her/hers) – Cleveland Clinic
• 9:30 AM – 11:30 AM CST

  MP08-11: Body composition can predict oncological outcome in non-muscle invasive bladder cancer patients who receive intravesical instillation with Bacillus Calmette-Guerin after transurethral resection of bladder tumor
  

  Poster Presenter: FanTing Liao, MD
• 9:30 AM – 11:30 AM CST

  MP08-12: Sequential Intravesical Gemcitabine and Docetaxel for Treatment-Naive and Previously Treated Intermediate-Risk Non-Muscle Invasive Bladder Cancer
  

  Poster Presenter: Ian Mitchell Mcelree, MS,BS
• 9:30 AM – 11:30 AM CST

  MP08-13: Prognostic Value of Micrometric Substaging in pT1 Bladder Cancer Patients Treated with En Bloc Transurethral Resection
  

  Poster Presenter: Takafumi Yanagisawa, MD – The Jikei University School of Medicine
• 9:30 AM – 11:30 AM CST

  MP08-14: Long term outcomes of repeated mitomycin C instillation in Low risk and Intermediate risk Non-Muscle Invasive Bladder Cancer patients
  

  Poster Presenter: Pietro Scilipoti, MD (he/him/his) – IRCCS Ospedale San Raffaele, Milan
• 9:30 AM – 11:30 AM CST

  MP08-15: The role of flexible blue light cystoscopy in surveillance of non-muscle invasive bladder cancer. Results from a Nordic registry
  

  Poster Presenter: Karsten Zieger, MD,PhD (he/him/his) – Department Urology, Lillebaelt Hospital
• 9:30 AM – 11:30 AM CST

  MP08-16: Comparison of Intravesical Therapy and Surgery as Treatment Options for Recurrent Bladder Cancer (CISTO): Collection of Patient-Reported Outcomes
  

  Poster Presenter: John Lawrence Gore, MD – University of Washington
• 9:30 AM – 11:30 AM CST

  MP08-17: Bacillus Calmette–Guérin strains don’t matter: Results from a territory-wide retrospective cohort study
  

  Poster Presenter: Kang Liu
• 9:30 AM – 11:30 AM CST

  MP08-19: Novel Urine-Based DNA Methylation Biomarkers for Urothelial Bladder Carcinoma Detection in Patients with Hematuria
  

  Poster Presenter: Amr A. Elsawy